Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001722649-17-000001
Filing Date
2017-11-22
Accepted
2017-11-22 08:39:28
Documents
1
Period of Report
2017-10-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2452
  Complete submission text file 0001722649-17-000001.txt   3886
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Issuer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address C/O IMMUDYNE, INC. 1460 BROADWAY NEW YORK NY 10036
Business Address
Galluppi Stefan (Reporting) CIK: 0001722649 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55857 | Film No.: 171218427